Found: 31
Select item for more details and to access through your institution.
Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304552
- By:
- Publication type:
- Article
A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN‐035.
- Published in:
- Journal of the International AIDS Society, 2024, v. 27, n. 3, p. 1, doi. 10.1002/jia2.26219
- By:
- Publication type:
- Article
Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States.
- Published in:
- Journal of the International AIDS Society, 2024, v. 27, n. 3, p. 1, doi. 10.1002/jia2.26223
- By:
- Publication type:
- Article
A latent trajectory analysis of young sexual and gender minorities' adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial).
- Published in:
- BMC Public Health, 2023, v. 23, p. 1, doi. 10.1186/s12889-023-17368-y
- By:
- Publication type:
- Article
A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035).
- Published in:
- PLoS ONE, 2023, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0284339
- By:
- Publication type:
- Article
SAFETY AND PK/PD OF A TENOFOVIR ALAFENAMIDE/ELVITEGRAVIR INSERT ADMINISTERED RECTALLY.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 67
- By:
- Publication type:
- Article
Acceptability of PC-1005 Gel Administered Rectally to HIV-1 Seronegative Adults at Three Different Volume Levels (MTN-037).
- Published in:
- AIDS Education & Prevention, 2022, v. 34, n. 4, p. 257, doi. 10.1521/aeap.2022.34.4.257
- By:
- Publication type:
- Article
Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial.
- Published in:
- Journal of Women's Health (15409996), 2022, v. 31, n. 7, p. 1029, doi. 10.1089/jwh.2021.0121
- By:
- Publication type:
- Article
Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026).
- Published in:
- AIDS & Behavior, 2022, v. 26, n. 5, p. 1333, doi. 10.1007/s10461-021-03490-8
- By:
- Publication type:
- Article
Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women.
- Published in:
- AIDS Patient Care & STDs, 2022, v. 36, n. 3, p. 97, doi. 10.1089/apc.2022.0002
- By:
- Publication type:
- Article
Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring.
- Published in:
- PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263664
- By:
- Publication type:
- Article
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States.
- Published in:
- Journal of the International AIDS Society, 2021, v. 24, n. 6, p. 1, doi. 10.1002/jia2.25747
- By:
- Publication type:
- Article
A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.
- Published in:
- AIDS & Behavior, 2020, v. 24, n. 2, p. 607, doi. 10.1007/s10461-019-02457-0
- By:
- Publication type:
- Article
1733. Voriconazole Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplant: How Much Is Enough, Are Low Voriconazole Levels Associated With Opportunistic Infections, and What Are the Reasons for Discontinuation?
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S635, doi. 10.1093/ofid/ofz360.1596
- By:
- Publication type:
- Article
Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 7, p. 1136, doi. 10.1093/cid/ciy653
- By:
- Publication type:
- Article
Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 7, p. 1144, doi. 10.1093/cid/ciy654
- By:
- Publication type:
- Article
Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States.
- Published in:
- AIDS & Behavior, 2016, v. 20, n. 11, p. 2644, doi. 10.1007/s10461-016-1299-8
- By:
- Publication type:
- Article
Integration of gross anatomy in an organ system-based medical curriculum: Strategies and challenges.
- Published in:
- Anatomical Sciences Education, 2015, v. 8, n. 3, p. 266, doi. 10.1002/ase.1483
- By:
- Publication type:
- Article
Mucosal effects of tenofovir 1% gel.
- Published in:
- eLife, 2015, p. 1, doi. 10.7554/eLife.04525.001
- By:
- Publication type:
- Article
A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007).
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060147
- By:
- Publication type:
- Article
Adherence and Acceptability in MTN 001: A Randomized Cross-Over Trial of Daily Oral and Topical Tenofovir for HIV Prevention in Women.
- Published in:
- AIDS & Behavior, 2013, v. 17, n. 2, p. 737, doi. 10.1007/s10461-012-0333-8
- By:
- Publication type:
- Article
MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0055013
- By:
- Publication type:
- Article
Antiviral Agents, Vaccines, and Immunotherapies.
- Published in:
- 2006
- By:
- Publication type:
- Book Review
Trends in Cancer Incidence Rates among HIV-Infected Patients.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Trends in Cancer Incidence Rates among HIV-Infected Patients.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Trends in AIDS-Defining and Non--AIDS-Defining Malignancies among HIV-Infected Patients: 1989--2002.
- Published in:
- Clinical Infectious Diseases, 2004, v. 39, n. 9, p. 1380, doi. 10.1086/424883
- By:
- Publication type:
- Article
A Prospective Study of Genital Herpes Simplex Virus Type 2 Infection in Human Immunodeficiency Virus Type 1 (HIV-1)-Seropositive Women: Correlations with CD4 Cell Count and Plasma HIV-1 RNA Level.
- Published in:
- Clinical Infectious Diseases, 2003, v. 36, n. 2, p. 207, doi. 10.1086/345440
- By:
- Publication type:
- Article
Comparative Analysis of Commercial Assays for the Detection and Quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Plasma from Patients Infected with HIV-1 Subtype C.
- Published in:
- Clinical Infectious Diseases, 2002, v. 35, n. 3, p. 323, doi. 10.1086/341490
- By:
- Publication type:
- Article
Prolonged Suppression of Human Immunodeficiency Virus Type 1 RNA during Dual Nucleoside...
- Published in:
- Clinical Infectious Diseases, 2000, v. 31, n. 4, p. 1095, doi. 10.1086/318143
- By:
- Publication type:
- Article
Endocarditis at the Millennium.
- Published in:
- Journal of Infectious Diseases, 1999, v. 179, p. S360, doi. 10.1086/513840
- By:
- Publication type:
- Article
Use of Statistics and Scientific Inference: Odds Ratios, Likelihood Ratio, and Receiving Operating Characteristic Curves.
- Published in:
- Journal of Infectious Diseases, 1998, v. 178, n. 3, p. 921, doi. 10.1086/515359
- By:
- Publication type:
- Article